John G. Emery

2.4k total citations · 1 hit paper
20 papers, 2.0k citations indexed

About

John G. Emery is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, John G. Emery has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in John G. Emery's work include Immune Response and Inflammation (5 papers), NF-κB Signaling Pathways (4 papers) and Cancer-related gene regulation (3 papers). John G. Emery is often cited by papers focused on Immune Response and Inflammation (5 papers), NF-κB Signaling Pathways (4 papers) and Cancer-related gene regulation (3 papers). John G. Emery collaborates with scholars based in United States, Ireland and Germany. John G. Emery's co-authors include Peter R. Young, Keith C. Deen, Sally D. Lyn, Peter McDonnell, Robert A. Dodds, Martin Rosenberg, Carol Silverman, Edward R. Appelbaum, Edward Dul and Ian E. James and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

John G. Emery

20 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL

1998 989 citations John G. Emery, Peter McDonnell et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John G. Emery United States	16	1.4k	702	611	433	168	20	2.0k
David J. Rieman United States	21	1.5k 1.1×	418 0.6×	862 1.4×	488 1.1×	77 0.5×	35	2.5k
Daniel Branstetter United States	21	1.0k 0.8×	387 0.6×	808 1.3×	386 0.9×	74 0.4×	40	2.0k
Michael J. Rauh Canada	22	1.2k 0.9×	951 1.4×	529 0.9×	348 0.8×	182 1.1×	73	2.7k
Masahiro Shiroo United Kingdom	17	709 0.5×	564 0.8×	378 0.6×	195 0.5×	70 0.4×	24	1.4k
Yoshinori Naoe Japan	27	1.3k 0.9×	1.4k 1.9×	820 1.3×	259 0.6×	152 0.9×	60	3.0k
Changhua Ji United States	24	883 0.6×	281 0.4×	495 0.8×	128 0.3×	169 1.0×	57	1.7k
Daniel T. Starczynowski United States	32	1.8k 1.3×	1.3k 1.8×	430 0.7×	1.1k 2.5×	145 0.9×	89	3.4k
Emmanuel Karouzakis Switzerland	20	1.0k 0.8×	481 0.7×	279 0.5×	460 1.1×	86 0.5×	30	1.9k
M Tohidast-Akrad Austria	18	1.4k 1.0×	491 0.7×	851 1.4×	389 0.9×	64 0.4×	31	2.5k
Ji‐Liang Li China	17	914 0.7×	173 0.2×	291 0.5×	609 1.4×	204 1.2×	41	1.6k

Countries citing papers authored by John G. Emery

Since Specialization

Citations

This map shows the geographic impact of John G. Emery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Emery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Emery more than expected).

Fields of papers citing papers by John G. Emery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Emery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Emery. The network helps show where John G. Emery may publish in the future.

Co-authorship network of co-authors of John G. Emery

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Emery. A scholar is included among the top collaborators of John G. Emery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Emery. John G. Emery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

West, Kip A., Sanjay Kumar, Martin Scott, et al.. (2023). BOS-371, a monoclonal antibody against IL1RAP: Characterization in preclinical models of AML.. Journal of Clinical Oncology. 41(16_suppl). 7030–7030. 2 indexed citations

2.

Qin, Donghui, Xiaojuan Lin, Yan Chen, et al.. (2021). Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors. ACS Medicinal Chemistry Letters. 12(6). 1005–1010. 7 indexed citations

3.

Nunes, João Soares, Xiao Qing Lewell, John G. Emery, et al.. (2019). Targeting IRAK4 for Degradation with PROTACs. ACS Medicinal Chemistry Letters. 10(7). 1081–1085. 100 indexed citations

4.

Laping, Nicholas J., Michael P. DeMartino, Joshua E. Cottom, et al.. (2017). TLR2 agonism reverses chemotherapy-induced neutropenia in Macaca fascicularis. Blood Advances. 1(26). 2553–2562. 2 indexed citations

5.

Thomson, Douglas W., Marcus Bantscheff, R. Edward Benson, et al.. (2017). Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines. Journal of Medicinal Chemistry. 60(13). 5455–5471. 24 indexed citations

6.

Yu, Jong W., Sandy Hoffman, Allison M. Beal, et al.. (2015). MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses. PLoS ONE. 10(5). e0127083–e0127083. 66 indexed citations

7.

Rickard, David J., Clark A. Sehon, Viera Kasparcova, et al.. (2014). Identification of Selective Small Molecule Inhibitors of the Nucleotide-Binding Oligomerization Domain 1 (NOD1) Signaling Pathway. PLoS ONE. 9(5). e96737–e96737. 17 indexed citations

8.

Rickard, David J., Clark A. Sehon, Viera Kasparcova, et al.. (2013). Identification of Benzimidazole Diamides as Selective Inhibitors of the Nucleotide-Binding Oligomerization Domain 2 (NOD2) Signaling Pathway. PLoS ONE. 8(8). e69619–e69619. 44 indexed citations

9.

Pendrak, Israil, John G. Emery, Daniel P. Nadeau, et al.. (2001). Antagonism of oestrogen action in human breast and endometrial cells in vitro: potential novel antitumour agents. Cancer Chemotherapy and Pharmacology. 47(5). 437–443. 16 indexed citations

10.

Emery, John G., Eliot H. Ohlstein, & Michael Jaye. (2001). Therapeutic modulation of transcription factor activity. Trends in Pharmacological Sciences. 22(5). 233–240. 28 indexed citations

11.

Connor, J.R., Robert A. Dodds, John G. Emery, et al.. (2000). Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization. Osteoarthritis and Cartilage. 8(2). 87–95. 64 indexed citations

12.

Prichett, William P., Amanda J. Patton, John G. Emery, et al.. (2000). Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone. Journal of Cellular Biochemistry. 76(4). 639–639. 1 indexed citations

13.

Prichett, William P., Amanda J. Patton, John G. Emery, et al.. (2000). Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone. Journal of Cellular Biochemistry. 76(4). 639–650. 20 indexed citations

14.

Gowen, Maxine, John G. Emery, & Sanjay Kumar. (2000). Emerging therapies for osteoporosis. 5(1). 1–43. 26 indexed citations

15.

Emery, John G., Peter McDonnell, Keith C. Deen, et al.. (1998). Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL. Journal of Biological Chemistry. 273(23). 14363–14367. 989 indexed citations breakdown →

16.

McDonnell, Peter, Michael Brigham‐Burke, Sally D. Lyn, et al.. (1998). Herpesvirus Entry Mediator Ligand (HVEM-L), a Novel Ligand for HVEM/TR2, Stimulates Proliferation of T Cells and Inhibits HT29 Cell Growth. Journal of Biological Chemistry. 273(42). 27548–27556. 196 indexed citations

17.

Tan, K. B., Manjula Reddy, Peter R. Young, et al.. (1997). Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene. 204(1-2). 35–46. 229 indexed citations

18.

Liebhaber, Stephen A., John G. Emery, Margrit Urbanek, Xinkang Wang, & Nancy E. Cooke. (1990). Characterization of a human cDNA encoding a widely expressed and highly conserved cysteine-rich protein with an unusual zinc-finger motif. Nucleic Acids Research. 18(13). 3871–3879. 74 indexed citations

19.

Mongeau, R., et al.. (1990). Effect of dietary fiber concentrated from celery, parsnip, and rutabaga on intestinal function, serum cholesterol, and blood glucose response in rats. Journal of Agricultural and Food Chemistry. 38(1). 195–200. 23 indexed citations

20.

Cooke, Nancy E., John A. Ray, John G. Emery, & Stephen A. Liebhaber. (1988). Two distinct species of human growth hormone-variant mRNA in the human placenta predict the expression of novel growth hormone proteins.. Journal of Biological Chemistry. 263(18). 9001–9006. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact